ImmunoSolv merges to avoid ‘one trick pony’ syndrome

Edinburgh, Scotland-based ImmunoSolv is merging with Aberdeen's Grampian BioConsultants, combining the two companies' technical know-how to further explore the biology of cell death. ImmunoSolv also announced that it has raised £500,000 from Grampian BioPartners, the Scottish Enterprise Scottish Co-Investment Fund and the University of Edinburgh. The new company will operate under the ImmunoSolv name, combining a complementary "portfolio of immunology and...